Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $5.19 Million - $6.65 Million
87,821 Added 702.57%
100,321 $7.42 Million
Q3 2023

Nov 14, 2023

SELL
$65.94 - $99.04 $825,634 - $1.24 Million
-12,521 Reduced 50.04%
12,500 $853,000
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $1.14 Million - $1.72 Million
18,141 Added 263.68%
25,021 $2.35 Million
Q1 2023

May 15, 2023

SELL
$47.19 - $70.77 $855,082 - $1.28 Million
-18,120 Reduced 72.48%
6,880 $467,000
Q4 2022

Feb 14, 2023

SELL
$30.35 - $53.15 $1.08 Million - $1.89 Million
-35,500 Reduced 58.68%
25,000 $1.24 Million
Q3 2022

Nov 14, 2022

SELL
$31.97 - $49.37 $58,569 - $90,445
-1,832 Reduced 2.94%
60,500 $1.97 Million
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $1.14 Million - $2.44 Million
32,043 Added 105.79%
62,332 $2.46 Million
Q1 2022

May 16, 2022

BUY
$57.56 - $82.54 $843,829 - $1.21 Million
14,660 Added 93.8%
30,289 $2.12 Million
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $4,712 - $6,544
-65 Reduced 0.41%
15,629 $1.22 Million
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $219,102 - $301,193
2,428 Added 18.3%
15,694 $1.5 Million
Q2 2021

Aug 16, 2021

BUY
$93.66 - $139.27 $594,741 - $884,364
6,350 Added 91.82%
13,266 $1.65 Million
Q1 2021

May 14, 2021

SELL
$116.57 - $155.01 $16,086 - $21,391
-138 Reduced 1.96%
6,916 $911,000
Q4 2020

Feb 16, 2021

SELL
$99.61 - $142.12 $2.85 Million - $4.07 Million
-28,614 Reduced 80.22%
7,054 $935,000
Q3 2020

Nov 16, 2020

BUY
$72.92 - $102.01 $28,876 - $40,395
396 Added 1.12%
35,668 $3.64 Million
Q2 2020

Aug 14, 2020

SELL
$55.75 - $92.75 $44,321 - $73,736
-795 Reduced 2.2%
35,272 $3.07 Million
Q1 2020

May 15, 2020

BUY
$37.9 - $104.44 $893,189 - $2.46 Million
23,567 Added 188.54%
36,067 $2.09 Million
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $970,750 - $1.25 Million
12,500 New
12,500 $1.16 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.92B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.